Molina Healthcare (NYSE: MOH ) is expected to report Q2 earnings on July 25. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Molina Healthcare's revenues will grow 4.8% and EPS will turn positive
The average estimate for revenue is $1.61 billion. On the bottom line, the average EPS estimate is $0.31.
Last quarter, Molina Healthcare logged revenue of $1.59 billion. GAAP reported sales were 16% higher than the prior-year quarter's $1.37 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.64. GAAP EPS of $0.64 for Q1 were 64% higher than the prior-year quarter's $0.39 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 19.0%, 130 basis points better than the prior-year quarter. Operating margin was 4.2%, 180 basis points better than the prior-year quarter. Net margin was 1.9%, 60 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $6.95 billion. The average EPS estimate is $1.61.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 133 members out of 145 rating the stock outperform, and 12 members rating it underperform. Among 47 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 43 give Molina Healthcare a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Molina Healthcare is outperform, with an average price target of $35.82.
Is Molina Healthcare the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Molina Healthcare to My Watchlist.